Time from oncology medicine approval to patient access in Europe 2023, by country
This statistic displays the average time between an oncology medicine gaining marketing authorization and patient access in European countries as of January 5, 2023. According to the data, in Germany the average time between authorization and access for oncology medicines (for drugs launchend from 2018 to 2021) was 102 days, compared to nearly one thousand days in Romania.